| Literature DB >> 28895887 |
Imelda Angeles-Agdeppa1, Clarita R Magsadia2, Grant J Aaron3, Beate B Lloyd4, David C Hilmers5, Zulfiqar A Bhutta6.
Abstract
This study evaluated the effects of a multi-micronutrient fortified juice drink given in different frequencies of consumption on hemoglobin (Hb) concentration of schoolchildren. Hb was measured in 2423 schoolchildren aged 6- to 9-years-old at baseline. All anemic children (n = 246) were randomly allocated into groups: Daily dose (HD: high dose), 5X/week (MD: Moderate Dose), 3X/week (LD: Low Dose) and unfortified (Control). Pre- and post-study measurements of micronutrients were collected from 228 children. At the endpoint, significant Hb increases were observed in all groups, but there was no significant difference between groups. There was a significant reduction in anemia prevalence in all groups from 100% to 36% (Control), 30% (LD), 23% (MD) and 26% (HD). No dose-response effect was observed in Hb in this population. Most likely, this resulted from better than expected micronutrient status and lower than expected severity of anemia and micronutrient deficiencies in this cohort. It is unlikely that the addition of a fortified beverage to school feeding programs in this population would have a positive impact. Whether such an intervention would be cost-effective as a preventative approach needs to be assessed. This study demonstrates the importance of targeting such interventions to appropriate populations.Entities:
Keywords: dose response 2; hemoglobin 1; multi-nutrient fortified juice drink 3
Mesh:
Substances:
Year: 2017 PMID: 28895887 PMCID: PMC5622762 DOI: 10.3390/nu9091002
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Consort flow diagram.
Nutrient composition a of the unfortified and fortified drinks.
| Nutrients | Unfortified | Fortified | ||
|---|---|---|---|---|
| Amount/200 mL Serving | % RENI b for 6–9 Years | Amount/200 mL Serving | %RENI b for 6–9 Years | |
| Energy (kcal) | 63.43 | 3.96 | 60.34 | 3.77 |
| Carbohydrates (g) | 15.74 | 99.23 | 15.04 | 99.70 |
| Vitamins | ||||
| 23.78 | 5.94 | 97.00 | 24.25 | |
| 0.01 | 1.43 | 0.41 | 58.57 | |
| 0.00 | 0.29 | 0.34 | 48.57 | |
| 0.03 | 0.29 | 6.90 | 76.67 | |
| 0.00 | 0.00 | 0.86 | 114.23 | |
| 0.00 | 0.00 | 165.00 | 55.00 | |
| 3.13 | 34.73 | 94.90 | 210.89 | |
| 0.00 | 0.00 | 145.90 | 72.95 | |
| 0.00 | 0.00 | 4.20 | 31.82 | |
| Minerals | ||||
| 0.00 | 0.00 | 154.00 | 22.00 | |
| 0.02 | 0.16 | 5.43 | 54.30 | |
| 0.00 | 0.00 | 5.60 | 109.80 | |
| 4.03 | 0.81 | 64.40 | 12.88 | |
| 0.79 | 0.88 | 0.79 | 0.88 | |
| 33.10 | 2.07 | 33.00 | 2.06 | |
a Based on the results of analysis; b Based on the RENI (Recommended Energy and Nutrient Intake) of the PDRI (Philippine Dietary Recommended Intake) [14].
Distribution of children by socio-economic and demographic characteristics at baseline by group.
| Characteristics | Control | Low Dose (LD) | Moderate Dose (MD) | High Dose (HD) | Total | |
|---|---|---|---|---|---|---|
| ( | ( | ( | ( | ( | ||
| Age of study child, mean (SE) | 7.3 (0.1) | 7.2 (0.1) | 7.4 (0.1) | 7.3 (0.1) | 7.3 (0.0) | 0.90 |
| Age Group | 0.60 | |||||
| 24 (41.4) | 25 (44.6) | 26 (46.4) | 23 (39.7) | 98 (43.0) | ||
| 20 (34.5) | 16 (28.6) | 16 (28.6) | 23 (39.7) | 75 (32.9) | ||
| 14 (24.1) | 15 (26.8) | 14 (25.0) | 12 (20.7) | 55 (24.1) | ||
| Sex | 0.60 | |||||
| 29 (50.0) | 24 (42.9) | 23 (41.1) | 30 (51.7) | 106 (46.5) | ||
| 29 (50.0) | 32 (57.1) | 33 (58.9) | 28 (48.3) | 122 (53.5) | ||
| Age of Respondent, mean (SE) | 36.6 (1.3) | 34.5 (1.4) | 37.5 (1.1) | 35.6 (1.1) | 36.0 (0.6) | 0.25 |
| Family Type | 0.92 | |||||
| 39 (67.2) | 38 (67.9) | 40 (71.4) | 38 (65.5) | 155 (68.0) | ||
| 19 (32.8) | 18 (32.1) | 16 (28.6) | 20 (34.5) | 73 (32.0) | ||
| Household Size, mean (SE) | 6.3 (0.3) | 6.5 (0.4) | 5.9 (0.3) | 6.4 (0.2) | 6.3 (0.2) | 0.55 |
| Main Occupation of Father | 0.15 | |||||
| 17 (29.3) | 10 (17.9) | 5 (8.9) | 7 (12.1) | 39 (17.1) | ||
| 26 (44.8) | 20 (35.7) | 25 (44.6) | 24 (41.4) | 95 (41.7) | ||
| 6 (10.3) | 9 (16.1) | 11 (19.6) | 11 (19) | 37 (16.2) | ||
| 9 (15.5) | 17 (30.4) | 15 (26.8) | 16 (27.5) | 57 (25.1) | ||
| Number of Earning Family Members | 0.02 * | |||||
| 24 (41.4) | 29 (51.8) | 31 (55.4) | 34 (58.6) | 118 (51.8) | ||
| 31 (53.4) | 21 (37.5) | 24 (42.9) | 14 (24.1) | 90 (39.5) | ||
| 3 (5.1) | 6 (10.7) | 1 (1.8) | 10 (17.1) | 20 (8.8) | ||
| Estimated Total Monthly Family Income in Philippine Peso, mean (SE) | 12,503.62 (1,088.12) | 13,164.79 (1,020.72) | 15,146.43 (1,271.31) | 14,944.62 (1,152.04) | 13,936.08 (569.42) | 0.27 |
| Average Daily Food Expenditure in Philippine Peso, mean (SE) | 242.86 (13.56) | 276.64 (21.10) | 235.54 (14.17) | 269.66 (14.30) | 256.18 (8.04) | 0.20 |
| Status of residential lot | 0.02 * | |||||
| 26 (44.8) | 21 (37.5) | 18 (32.1) | 14 (24.1) | 79 (34.6) | ||
| 19 (32.8) | 12 (21.4) | 9 (16.1) | 20 (34.5) | 60 (26.3) | ||
| 12 (20.7) | 17 (30.4) | 17 (30.4) | 14 (24.1) | 60 (26.3) | ||
1 Pearson’s χ2 test of independence and f-test; * p < 0.05.
Mean values and percent distribution of iron biomarkers of schoolchildren by group by period.
| Biomarkers | Control ( | Low Dose ( | Moderate Dose ( | High Dose ( | |
|---|---|---|---|---|---|
| Mean (SE) | Mean (SE) | Mean (SE) | Mean (SE) | ||
| Hemoglobin (g/dL) | |||||
| 10.8 (0.1) | 11.1 (0.1) | 11.1 (0.0) | 11.0 (0.1) | 0.01 * | |
| 11.7 (0.1) | 11.9 (0.1) | 11.9 (0.1) | 12.0 (0.1) | 0.50 | |
| 0.9 (0.1) | 0.9 (0.1) | 0.8 (0.1) | 1.0 (0.1) | 0.47 | |
| No. (%) Anemia | |||||
| 58 (100) | 56 (100) | 56 (100) | 58 (100) | 1.00 | |
| 21 (36.2) | 17 (30.4) | 13 (23.2) | 15 (25.9) | 0.44 | |
| 37 (63.8) | 39 (69.6) | 43 (76.8) | 43 (74.1) | ||
| Serum ferritin(μg/L) | |||||
| 66.4 (5.1) | 68.7 (4.4) | 73.5 (5.6) | 68.4 (3.8) | 0.75 | |
| 65.5 (4.3) | 72.0 (4.3) | 74.2 (4.8) | 71.4 (3.3) | 0.50 | |
| 0.9 (4.5) | 3.2 (3.5) | 0.7 (4.6) | 2.9 (3.8) | 0.88 | |
| 59.0 (4.1) | 64.5 (3.9) | 66.4 (4.6) | 64.4 (3.5) | 0.61 | |
| 62.3 (4.2) | 66.7 (3.8) | 70.9 (4.5) | 66.6 (2.6) | 0.48 | |
| 3.2 (3.52 | 2.2 (3.0) | 4.5 (3.2) | 2.2 (3.2) | 0.95 | |
| No. (%) Iron deficiency using adjusted ferritin values | |||||
| 9 (15.2) | 3 (5.4) | 4 (7.1) | 1 (1.7) | 0.60 | |
| 5 (8.6) | 3 (5.4) | 4 (7.1) | 3 (5.1) | 0.48 | |
| 4 (6.6) | 0 (0.0) | 0 (0.0) | 2 (3.4) | ||
| Serum transferrin receptors (mg/L) | |||||
| 7.2 (0.3) | 6.8 (0.2) | 6.7 (0.2) | 6.9 (0.26) | 0.54 | |
| 7.2 (0.3 | 7.0 (0.3) | 6.9 (0.2) | 7.0 (0.31) | 0.83 | |
| 0.0 (0.2) | 0.2 (0.2) | 0.2(0.1) | 0.1 (0.1) | ||
| Low serum transferrin receptor ( | |||||
| 10 (17.2) | 6 (10.7) | 5 (8.9) | 8 (13.8) | 0.56 | |
| 9 (15.5) | 10 (17.9) | 7 (12.5) | 8 (13.8) | 0.87 | |
| 1 (1.7) | 4 (7.1) | 2 (3.6) | 0 (0.0) | ||
| Body iron stores (mg/kg/body weight) | |||||
| 6.0 (0.34) | 6.6 (0.26) | 6.7 (0.29) | 6.59 (0.24) | 0.338 | |
| 6.0 (0.35) | 6.7 (0.26) | 6.8 (0.24) | 6.8 (0.2) | 0.128 | |
| 0.0 (0.2) | 0.06 (0.18) | 0.09 (0.24) | 0.21 (0.19) | ||
1 f-test using one-way ANOVA; * significant at α = 0.05; a Adjusted ferritin level was done using the correction factors by stage (Thurnham CF).
Mean of secondary biomarkers of study children by group by period.
| Biochemical | Control | Low Dose | Moderate Dose | High Dose | |
|---|---|---|---|---|---|
| ( | ( | ( | ( | ||
| Mean (SE) | Mean (SE) | Mean (SE) | Mean (SE) | ||
| Baseline | 0.94 (0.03) | 1 (0.03) | 1.03 (0.04) | 1.00 (0.03) | 0.16 |
| Endpoint | 1.05 (0.03) | 1.11 (0.04) | 1.11 (0.03) | 1.11 (0.03) | 0.48 |
| Difference | 0.12 (0.03) | 0.11 (0.04) | 0.07 (0.03) | 0.10 (0.03) | |
| Baseline | 64 (3) | 63 (3) | 64 (3) | 64 (2) | 0.98 |
| Endpoint | 68 (2) | 66 (2) | 73 (3) | 67 (3) | 0.24 |
| Difference | 4 (3) | 3 (3) | 9 (4) | 3 (3) | |
| Baseline | 0.22 (0.01) | 0.23 (0.02) | 0.24 (0.02) | 0.22 (0.02) | 0.74 |
| Endpoint | 0.24 (0.02) | 0.28 (0.02) | 0.36 (0.03) | 0.30 (0.02) | 0.01 * |
| Difference | 0.02 (0.02) | 0.05 (0.02) | 0.11 (0.02) | 0.08 (0.02) | |
| 0.23 | 0.01 | 0.00 | 0.00 | ||
| Baseline | 60 (2) | 64 (2) | 64 (3) | 69 (3) | 0.44 |
| Endpoint | 65 (2) | 68 (2) | 69 (2) | 73 (2) | 0.11 |
| Difference | 5 (1) | 3 (2) | 5 (2) | 7 (1) | |
* Significant at α = 0.05; 1 f-test using one-way ANOVA; 2 t-test using paired samples; a p < 0.7 µmol/L defines Low RBP and between 0.7 µmol/L and 1.05 µmol/L for moderate deficiency; b p < 65 µg/dL (9.9 μmol/L) defines zinc deficiency; c p < 0.20 µg/dL defines vit. C deficiency; d p < 75 nmol/L defines vit. D deficiency.
Mean per capita nutrient intake of Children and Percentage meeting the EAR with fortified juice drink by group by period control.
| Nutrients | Control | % | Low Dose | % | Moderate Dose | % | High Dose | % |
|---|---|---|---|---|---|---|---|---|
| ( | ( | ( | ( | |||||
| Mean ± SE | Mean ± SE | Mean ± SE | Mean ± SE | |||||
| Vitamin A (µg RE) | ||||||||
| 499.8 ± 131.1 | 51.7 | 470.5 ± 93.6 | 64.3 | 734.7 ± 338.3 | 58.9 | 404.1 ± 43.4 | 69 | |
| 484.6 ± 86.7 | 62.1 | 370.7 ± 27.0 | 62.5 | 384.3 ± 33.6 | 55.4 | 360.1 ± 26.0 | 67.2 | |
| −15.2 ± 158.8 | 10.3 | −99.8 ± 99.7 | −1.8 | −350.4 ± 344.5 | −3.6 | −44.0 ± 47.8 | −1.7 | |
| 1.6 | 2.1 | 2.0 | 2.2 | |||||
| Vitamin C (mg) | ||||||||
| 14.8 ± 2.4 | 22.4 | 26.2 ± 6.5 | 32.1 | 26.1 ± 6.7 | 30.4 | 49.5 ± 30.3 | 36.2 | |
| 17.1 ± 2.8 | 25.9 | 40.7 ± 3.6 | 80.4 | 58.5 ± 6.7 | 100 | 60.9 ± 2.3 | 100 | |
| 2.4 ± 3.3 | 3.4 | 14.5 ± 7.6 | 48.2 * | 32.4 ± 9.4 * | 69.6 * | 11.4 ± 30.6 | 63.8 * | |
| 16.8 | 68.6 | 74.0 | 87.6 | |||||
| Thiamin (mg) | ||||||||
| 0.7 ± 0.1 | 48.3 | 0.9 ± 0.1 | 62.5 | 0.8 ± 0.07 | 60.7 | 0.9 ± 0.1 | 74.1 | |
| 0.8 ± 0.1 | 55.2 | 0.8 ± 0.1 | 66.1 | 1.0 ± 0.1 | 76.8 | 1.1 ± 0.1 | 82.8 | |
| 0.1 ± 0.1 | 6.9 | 0.1 ± 0.1 | 3.6 | 0.2 ± 0.1 * | 16.1 * | 0.2 ± 0.1 | 8.6 | |
| 1.3 | 20.0 | 25.7 | 32.8 | |||||
| Riboflavin (mg) | ||||||||
| 0.6 ± 0.1 | 39.7 | 0.8 ± 0.07 | 57.1 | 0.8 ± 0.1 | 58.9 | 0.8 ± 0.1 | 63.8 | |
| 0.7 ± 0.1 | 55.2 | 0.7 ± 0.04 | 69.6 | 0.9 ± 0.1 | 78.6 | 0.8 ± 0.0 | 81 | |
| 0.1 ± 0.1 | 15.5 * | −0.0 ± 0.1 | 12.5 | 0.0 ± 0.1 | 19.6 * | 0.0 ± 0.1 | 17.2 * | |
| 0.0 | 18.5 | 24.6 | 33.3 | |||||
| Niacin (mg) | ||||||||
| 10.2 ± 0.6 | 70.7 | 12.5 ± 1.18 | 73.2 | 12.0 ± 1.2 | 76.8 | 14.6 ± 1.2 | 87.9 | |
| 11.2 ± 0.8 | 69 | 13.0 ± 0.64 | 94.6 | 13.7 ± 0.2 | 96.4 | 16.0 ± 0.8 | 98.3 | |
| 1.0 ± 1.0 | −1.7 | 0.5 ± 1.38 | 21.4 * | 1.7 ± 1.3 | 19.6 * | 1.4 ± 1.3 | 10.3 * | |
| 0.2 | 20.8 | 30.9 | 35.9 | |||||
| Calcium (mg) | ||||||||
| 284.3 ± 27.4 | 13.8 | 314.4 ± 23.3 | 19.6 | 373.6 ± 35.2 | 35.7 | 332.3 ± 24.8 | 19 | |
| 295.3 ± 26.8 | 15.5 | 342.1 ± 22.3 | 19.6 | 387.8 ± 33.2 | 30.4 | 359.1 ± 18.1 | 25.9 | |
| 11.0 ± 27.4 | 1.7 | 27.6 ± 26.2 | 0 | 14.3 ± 36.8 | −5.4 | 26.7 ± 28.3 | 6.9 | |
| 0.0 | 17.6 | 24.8 | 35.3 | |||||
| Iron (mg) | ||||||||
| 7.0 ± 0.4 | 29.3 | 7.7 ± 0.57 | 39.3 | 8.4 ± 0.9 | 35.7 | 7.8 ± 0.5 | 36.2 | |
| 7.6 ± 0.6 | 29.3 | 9.0 ± 0.49 | 53.6 | 9.1 ± 0.5 | 48.2 | 10.1 ± 0.5 | 62.1 | |
| 0.6 ± 0.8 | 0 | 1.2 ± 0.8 | 14.3 | 0.6 ± 1.1 | 12.5 | 2.4 ± 0.7 * | 25.9 * | |
| 0.3 | 23.1 | 35.4 | 42.3 |
1 f-test using one-way ANOVA; * significant at α = 0.05.